Literature DB >> 2101835

Sickle cell anemia and major organ failure.

D R Powars1.   

Abstract

Major organ failure in sickle cell anemia is the direct consequence of the sickle cell evoked vasculopathy. Major organ failure is first clinically apparent as autosplenectomy, then during childhood presents as cerebral infarction and atrophy, and finally culminates in young adulthood as end stage renal failure (glomerulosclerosis), sickle chronic lung disease, intracranial hemorrhage, retinopathy, disabling leg ulcers, and generalized osteonecrosis. The vascular damage begins years before the overt clinical symptoms are apparent with no pain to act as a signal. Organ damage is progressive and irreversible. The rate of progression is genetically controlled from birth. Except for the management of life-threatening infections that are associated with the non-functioning spleen, disease expression has not been altered by therapy. The focus of future clinical investigations must be the prevention of the vasculopathy and tissue damage which is induced by the sickle red cell.

Entities:  

Mesh:

Year:  1990        PMID: 2101835     DOI: 10.3109/03630269009046967

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  14 in total

1.  Current sickle cell disease management practices in Nigeria.

Authors:  N Galadanci; B J Wudil; T M Balogun; G O Ogunrinde; A Akinsulie; F Hasan-Hanga; A S Mohammed; M O Kehinde; J A Olaniyi; I N Diaku-Akinwumi; B J Brown; S Adeleke; O E Nnodu; I Emodi; S Ahmed; A O Osegbue; N Akinola; H I O Opara; S A Adegoke; J Aneke; A D Adekile
Journal:  Int Health       Date:  2013-10-10       Impact factor: 2.473

2.  Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT.

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Tiffani Taylor; Wynona Coles; Katherine Roskom; Delon Wilson; Elizabeth Wright; Neal Jeffries; Christopher J Gamper; Jonathan Powell; Leo Luznik; John F Tisdale
Journal:  Blood Adv       Date:  2017-04-19

3.  Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.

Authors:  Bolanle O P Musa; Geoffrey C Onyemelukwe; Joseph O Hambolu; Aisha I Mamman; Albarka H Isa
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

Review 4.  Myocardial infarction in sickle cell disease.

Authors:  Ishak A Mansi; Fred Rosner
Journal:  J Natl Med Assoc       Date:  2002-06       Impact factor: 1.798

5.  Leg ulcers in sickle cell disease: current patterns and practices.

Authors:  Kara-Marie H Delaney; Karen C Axelrod; Ashley Buscetta; Kathryn L Hassell; Patricia E Adams-Graves; Catherine Seamon; Gregory J Kato; Caterina P Minniti
Journal:  Hemoglobin       Date:  2013-04-19       Impact factor: 0.849

Review 6.  Pulmonary manifestations of sickle cell disease.

Authors:  A K Siddiqui; S Ahmed
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

7.  Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha.

Authors:  Nitin Patel; Caryn S Gonsalves; Punam Malik; Vijay K Kalra
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

8.  Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.

Authors:  Ravi Vats; Silvia Liu; Junjie Zhu; Dhanunjay Mukhi; Egemen Tutuncuoglu; Nayra Cardenes; Sucha Singh; Tomasz Brzoska; Karis Kosar; Mikhil Bamne; Jude Jonassaint; Adeola Adebayo Michael; Simon C Watkins; Cheryl Hillery; Xiaochao Ma; Kari Nejak-Bowen; Mauricio Rojas; Mark T Gladwin; Gregory J Kato; Sadeesh Ramakrishnan; Prithu Sundd; Satdarshan Pal Monga; Tirthadipa Pradhan-Sundd
Journal:  Hepatology       Date:  2020-11-13       Impact factor: 17.425

9.  A posttranslational modification of beta-actin contributes to the slow dissociation of the spectrin-protein 4.1-actin complex of irreversibly sickled cells.

Authors:  A Shartava; C A Monteiro; F A Bencsath; K Schneider; B T Chait; R Gussio; L A Casoria-Scott; A K Shah; C A Heuerman; S R Goodman
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

10.  Organ damage in sickle cell disease study (ORDISS): protocol for a longitudinal cohort study based in Ghana.

Authors:  Kofi A Anie; Vivian Paintsil; Ellis Owusu-Dabo; Daniel Ansong; Alex Osei-Akoto; Kwaku Ohene-Frempong; Kofi Aikins Amissah; Nicholas Addofoh; Ezekiel Bonwin Ackah; Amma Twumwa Owusu-Ansah; Solomon Fiifi Ofori-Acquah
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.